Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia.
暂无分享,去创建一个
P. Hof | M. Ehrlich | P. Gonzalez-Alegre | A. Méneret | L. Ozelius | J. Kottwitz | A. Morant | Tania Fuchs | G. Pérez-García | Maitane Ortiz-Virumbrales | Marta Ruíz | J. Bonet
[1] K. Lohmann,et al. THAP1, the gene mutated in DYT6 dystonia, autoregulates its own expression. , 2014, Biochimica et biophysica acta.
[2] A. Richter,et al. Genetic animal models of dystonia: Common features and diversities , 2014, Progress in Neurobiology.
[3] M. Ehrlich,et al. Dystonia type 6 gene product Thap1: identification of a 50 kDa DNA-binding species in neuronal nuclear fractions , 2014, Acta neuropathologica communications.
[4] W. Dauer,et al. TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration. , 2014, The Journal of clinical investigation.
[5] A. Blitzer,et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia , 2014, Molecular genetics & genomic medicine.
[6] H. Jinnah,et al. Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia , 2014, Neurobiology of Disease.
[7] H. Steiner,et al. Behavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons , 2013, Molecular Neurodegeneration.
[8] A. Pisani,et al. New genetic insights highlight ‘old’ ideas on motor dysfunction in dystonia , 2013, Trends in Neurosciences.
[9] M. LeDoux,et al. Emerging common molecular pathways for primary dystonia , 2013, Movement disorders : official journal of the Movement Disorder Society.
[10] S. Campagne,et al. NMR studies of a new family of DNA binding proteins: the THAP proteins , 2013, Journal of biomolecular NMR.
[11] S. Mcconnell,et al. A network of genetic repression and derepression specifies projection fates in the developing neocortex , 2012, Proceedings of the National Academy of Sciences.
[12] H. Jinnah,et al. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia , 2012, Neurobiology of Disease.
[13] L. Ozelius,et al. Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled‐coil domain , 2011, Journal of neurochemistry.
[14] C. Barnum,et al. Behavioral and Cellular Modulation of l-DOPA-Induced Dyskinesia by β-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat , 2011, Journal of Pharmacology and Experimental Therapeutics.
[15] D. Eidelberg,et al. Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging , 2011, Neurobiology of Disease.
[16] S. Lehéricy,et al. The functional neuroanatomy of dystonia , 2011, Neurobiology of Disease.
[17] S. Schneider,et al. Homozygous THAP1 mutations as cause of early‐onset generalized dystonia , 2011, Movement disorders : official journal of the Movement Disorder Society.
[18] K. Hashimoto,et al. Altered Dendritic Morphology of Purkinje cells in Dyt1 ΔGAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice , 2011, PloS one.
[19] John Meitzen,et al. β1‐Adrenergic receptors activate two distinct signaling pathways in striatal neurons , 2011, Journal of neurochemistry.
[20] Rogely Waite Boyce,et al. Design-based Stereology , 2010, Toxicologic pathology.
[21] M. Ehrlich,et al. Direct interaction between causative genes of DYT1 and DYT6 primary dystonia , 2010, Annals of neurology.
[22] K. Lohmann,et al. The dystonia gene DYT1 is repressed by the transcription factor THAP1 (DYT6) , 2010, Annals of neurology.
[23] M. Rice,et al. Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (ΔE) TorsinA in transgenic mice , 2010, Neurobiology of Disease.
[24] J. Berger,et al. THAP proteins target specific DNA sites through bipartite recognition of adjacent major and minor grooves , 2009, Nature Structural &Molecular Biology.
[25] D. Leroith,et al. High-Efficient FLPo Deleter Mice in C57BL/6J Background , 2009, PloS one.
[26] D. Tao,et al. Neural cell cycle dysregulation and central nervous system diseases , 2009, Progress in Neurobiology.
[27] S. Bressman,et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia , 2009, Nature Genetics.
[28] M. Ehrlich,et al. Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse. , 2008, Human molecular genetics.
[29] T. Wichmann. Commentary: Dopaminergic dysfunction in DYT1 dystonia , 2008, Experimental Neurology.
[30] X. Breakefield,et al. Dopamine release is impaired in a mouse model of DYT1 dystonia , 2007, Journal of neurochemistry.
[31] M. Hallett,et al. Do primary adult-onset focal dystonias share aetiological factors? , 2007, Brain : a journal of neurology.
[32] C. Mathé,et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. , 2007, Blood.
[33] M. Chesselet,et al. Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism , 2006, Behavioural pharmacology.
[34] A. Bentivoglio,et al. Non‐DYT1 early‐onset primary torsion dystonia: Comparison with DYT1 phenotype and review of the literature , 2006, Movement disorders : official journal of the Movement Disorder Society.
[35] C. Englund,et al. Development of the Deep Cerebellar Nuclei: Transcription Factors and Cell Migration from the Rhombic Lip , 2006, The Journal of Neuroscience.
[36] P. R. Hof,et al. Design-based stereology in neuroscience , 2005, Neuroscience.
[37] J. Girault,et al. cAMP and Extracellular Signal-Regulated Kinase Signaling in Response to d-Amphetamine and Methylphenidate in the Prefrontal Cortex in Vivo: Role of β1-Adrenoceptors , 2005, Molecular Pharmacology.
[38] C. Mathé,et al. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Baker,et al. mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] W. Schmidt,et al. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6‐hydroxydopamine‐induced partial degeneration of substantia nigra in rats , 2003, The European journal of neuroscience.
[41] Sophia Kossida,et al. The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase. , 2003, Trends in biochemical sciences.
[42] P. Thier,et al. Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant , 2002, The Journal of comparative neurology.
[43] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[44] R. Spang,et al. Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis , 2001, Molecular and Cellular Biology.
[45] K. L. Tucker. Methylated Cytosine and the Brain A New Base for Neuroscience , 2001, Neuron.
[46] Yusu Gu,et al. A Post-transcriptional Compensatory Pathway in Heterozygous Ventricular Myosin Light Chain 2-Deficient Mice Results in Lack of Gene Dosage Effect during Normal Cardiac Growth or Hypertrophy* , 1999, The Journal of Biological Chemistry.
[47] T. Hökfelt,et al. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. , 1996, Trends in pharmacological sciences.
[48] Emma Carrick,et al. Dopa‐responsive dystonia , 1994, Annals of neurology.
[49] R. Solaro,et al. Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. , 1998, Circulation research.
[50] K. Rajewsky,et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.
[51] K. Mizukawa,et al. MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior. , 1987, European neurology.